You Have Tried Everything. This Is What Comes After That.

Triptans. Beta blockers. CGRP inhibitors. Botox. Nerve blocks. The preventive medications, the rescue medications, the combinations your neurologist suggested when the first combination stopped working. If you have chronic or refractory migraine, you know this cycle intimately. You also know that none of it has given you your life back.

Migraine is the second leading cause of disability worldwide. For people with chronic migraine, defined as 15 or more headache days per month, and especially for those with refractory migraine who have failed multiple medication classes, the disability is real, daily, and profoundly isolating. You plan your week around whether you might be able to function. You cancel things. You live carefully and still lose days.

At Ketamine Wellness Infusions PA, located minutes from Lower Merion Township in Bala Cynwyd, we offer IV ketamine infusions for patients with chronic and refractory migraine who have not found adequate relief through conventional treatment. The clinical evidence for ketamine in this population is growing, the mechanism is neurologically specific, and for many patients, it represents the first meaningful relief they have experienced in years.

Our founder Jill Gabay is a senior CRNA with more than 30 years of anesthesia experience and a member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners. She is personally present for every infusion, every patient, every session.

If you have been through the standard migraine treatment ladder and are still suffering, schedule a consultation. There is more to try.

Why Migraine Is More Than a Headache

Migraine is a neurological disorder involving widespread dysregulation of brain excitability, pain amplification, and sensory processing. What most people experience as a severe headache is actually the surface symptom of a much deeper neurological event involving cortical spreading depression, trigeminal nerve sensitization, and in chronic migraine, a progressive state of central sensitization that keeps the brain in a state of persistent pain vulnerability.

Central sensitization is the reason chronic migraine is so resistant to treatment. Once the nervous system has reorganized around chronic pain, the brain does not simply respond to an absence of triggers. The pain-amplification circuitry has become self-sustaining. Standard migraine medications, whether acute or preventive, work upstream of this process. They address triggers, vascular mechanisms, or CGRP pathways. But they do not directly address the central sensitization that makes the brain so persistently reactive in the first place.

This is where IV ketamine's mechanism becomes relevant.

How IV Ketamine Treats Chronic and Refractory Migraine

Ketamine targets NMDA receptors, which are central to the mechanism of central sensitization driving chronic migraine. By blocking NMDA receptors, ketamine interrupts the reinforcement of pain pathways in the central nervous system, promoting neuroplasticity and allowing the sensitized pain circuitry to reset. Research published in Practical Neurology in 2024 noted that ketamine has at least 4 to 5 days of continuous infusion required in some studies to achieve meaningful reduction in allodynia, a hallmark marker of central sensitization in chronic migraine.

The clinical evidence for ketamine in refractory migraine is meaningful. A systematic review found that 100% of participants with migraine without aura experienced acute pain relief at a mean time of 44 minutes after IV infusion. A retrospective study of 77 patients with refractory chronic migraine who had failed previous aggressive outpatient and inpatient therapies found that IV subanesthetic ketamine reduced mean pain ratings by an average of 3.3 points from admission to discharge, with 71.4% of patients achieving at least a two-point improvement. Of those short-term responders, 27.3% maintained meaningful benefit at one-month follow-up.

A retrospective cohort study in Frontiers in Neurology found that IV ketamine was associated with a 50% or greater reduction in pain in 34.4% of migraine patients over a mean of 5.1 days. For patients with chronic cluster headache, a related condition involving similar central sensitization mechanisms, a systematic review found that 54% became pain-free within two weeks of ketamine infusion.

The consensus guidelines on IV ketamine for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists identify migraine among the chronic pain conditions for which IV ketamine has documented clinical utility.

This is not a first-line treatment for all migraine. It is most clearly indicated for patients who have failed multiple preventive medication classes and conventional interventional approaches, meaning it belongs at the end of a rigorous treatment ladder. For patients who have reached that point, the evidence is encouraging.

Who Is the Best Candidate for IV Ketamine for Migraine

IV ketamine for migraine is most appropriate for patients who meet one or more of the following criteria:

They have been diagnosed with chronic migraine, meaning 15 or more headache days per month for at least three months. They have failed three or more preventive medication classes, which may include beta blockers, anticonvulsants, tricyclic antidepressants, CGRP inhibitors, or Botox. Their migraine has been classified as refractory, meaning it has not responded adequately to inpatient or outpatient infusion protocols using other agents. Their quality of life is significantly impaired by migraine-related disability that has not been resolved by available treatments.

A consultation with our team will review your full migraine history, prior treatments, and current pain picture to determine whether IV ketamine is an appropriate next step.

What Treatment Looks Like at Our Clinic

Before your first infusion, Jill Gabay conducts a thorough consultation reviewing your complete migraine and medical history, your prior treatment responses, and your current medications. IV ketamine for refractory migraine is used in conjunction with your existing neurological care, not as a replacement for it. We work alongside your neurologist when appropriate.

The standard initial course consists of six IV ketamine infusions completed over approximately two to three weeks. Each session lasts 40 to 60 minutes in a calm, monitored room with blankets, an eye mask, and essential oil diffusers. Jill or a member of our care team is present throughout every infusion monitoring your vital signs. You are not alone in that room at any point.

After your series, Jill conducts personal follow-up check-ins to assess your pain response and guide your next steps. Some patients experience sustained relief following the initial series. Others benefit from periodic maintenance infusions. Your ongoing plan is based on your specific response.

Why Lower Merion Township Patients Choose Our Clinic

Our clinic at 146 Montgomery Ave, Suite 202 in Bala Cynwyd sits inside Lower Merion Township, accessible from Ardmore, Wynnewood, Narberth, Penn Valley, Bryn Mawr, and throughout the Main Line. You do not need to travel to Philadelphia or a hospital system to access experienced IV ketamine care.

Jill Gabay has more than 30 years of anesthesia experience. She understands pharmacology, dosing precision, and monitored infusion management at a level that makes a real clinical difference for complex pain patients. Her physician supervisor Dr. Rubin brings more than 20 years of experience as a board-certified oncologist and Clinical Associate Professor at Drexel University College of Medicine. We hold a 5.0 Google rating from patients whose conditions had not adequately responded to what came before.

Frequently Asked Questions About Migraine Treatment in Lower Merion Township